News | July 13, 2011

Akron Children's Hospital to Demonstrate Heart Ablation Procedure via Live Webcast

July 13, 2011 – Many children and teens suffering from tachycardia, or rapid heart rate, have relied on medication to regulate their heart rhythms and control symptoms such as fatigue, dizziness and fainting spells. However, doctors at the Akron Children's Hospital Arrhythmia Center have made great strides in curing tachycardia with minimally invasive procedures.

Their skills will be on display during a one-hour webcast that will be available beginning Thursday, July 14, at 6 p.m. (Eastern). The webcast will include footage from a cryoablation procedure, as well as interviews with Arrhythmia Center director John Clark, M.D., associate director Grace Smith, M.D., and the patient and family.

During the cryoablation procedure, electrode catheters – long, slender, flexible wires – are threaded into the heart to map or locate the precise area of the heart causing the irregular rhythm. Once identified, the surgeon destroys the abnormal heart tissue by freezing it off with nitrous oxide. In other cases, radiofrequency ablation is used to burn the affected area.

Clark and Smith recommend cryoablations as the primary therapy for children age 5 and older with rapid heart rates. Approved by the U.S. Food and Drugs Administration (FDA) in 2003, Akron Children's was the first pediatric hospital in Ohio to offer cryoablation, which cures 90 to 95 percent of patients.

Clark and Smith perform most cardiac ablations without radiation, an advancement significant to young patients at risk of lifelong cumulative radiation exposure through regular diagnostic procedures.

For more information: www.akronchildrens.org


Related Content

News

October 10, 2023 — Axon Therapies, a private company focused on addressing a root cause of heart failure, announced 6 ...

Home October 10, 2023
Home
News

August 9, 2023 — Boston Scientific Corporation announced it has received U.S. Food and Drug Administration (FDA) ...

Home August 09, 2023
Home
News

January 31, 2023 —Imricor, a global leader in real-time interventional cardiac magnetic resonance (iCMR) ablation ...

Home January 31, 2023
Home
News

December 21, 2022 — Stereotaxis, a global leader in robotic technologies for the treatment of cardiac arrhythmias ...

Home December 21, 2022
Home
News

October 24, 2022 — Acutus Medical, Inc, an arrhythmia management company focused on improving the way cardiac ...

Home October 24, 2022
Home
News

May 13, 2022 — Acutus Medical, an arrhythmia management company focused on improving the way cardiac arrhythmias are ...

Home May 13, 2022
Home
News

May 4, 2022 – Stereotaxis, the global leader in innovative robotic technologies for the treatment of cardiac arrhythmias ...

Home May 04, 2022
Home
News

April 5, 2021 — Acutus Medical today announced initial U.S. enrollments in the company’s AcQForce Flutter ...

Home April 05, 2021
Home
News

June 16, 2020 – The Montreal Heart Institute (MHI) and Thermedical, a developer of thermal-ablation systems to treat ...

Home June 16, 2020
Home
News

May 8, 2020 – Results from a first-in-human early feasibility study (EFS) using a saline enhanced radiofrequency (SERF) ...

Home May 08, 2020
Home
Subscribe Now